These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker? Grieco A; De Stefano V; Cassano A; Ciabattoni A; Garufi C; Astone A; Leone G; Barone C Dig Dis Sci; 1991 Jul; 36(7):990-2. PubMed ID: 1649042 [TBL] [Abstract][Full Text] [Related]
43. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906 [TBL] [Abstract][Full Text] [Related]
44. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis. Pasqualetti P; Casale R Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565 [TBL] [Abstract][Full Text] [Related]
45. Regulation of the thrombin time in cirrhosis. Braunstein KM; Kinard HB; Hepfer TW; Craig WR; Eurenius K Thromb Res; 1976 Oct; 9(4):301-17. PubMed ID: 136058 [No Abstract] [Full Text] [Related]
46. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Ben-Ari Z; Osman E; Hutton RA; Burroughs AK Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855 [TBL] [Abstract][Full Text] [Related]
47. Antithrombin III. Key factor in extracorporeal circulation. Ranucci M Minerva Anestesiol; 2002 May; 68(5):454-7. PubMed ID: 12029263 [TBL] [Abstract][Full Text] [Related]
48. Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis. Boneu B; Sie P; Caranobe C; Cassigneul J; Pascal J Thromb Haemost; 1982 Feb; 47(1):78. PubMed ID: 7071809 [No Abstract] [Full Text] [Related]